Our fourth dialogue in a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.

Following the publication of the EU’s Pharmaceutical Strategy by the European Commission, senior representatives of the upcoming EU Presidencies (Portugal & Slovenia) and the Netherlands offer their perspective on what should be prioritised and debate next steps in European pharmaceutical policy.